---
title: "ETEK: Yijing Investment plans to reduce its holdings by no more than 3%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262459210.md"
description: "According to the Zhitong Finance APP, ETEK announced that Yijing Investment plans to reduce its holdings of the company's shares by no more than 4.0108 million shares, which is no more than 3% of the company's total share capital, due to its own funding needs through centralized bidding and block trading"
datetime: "2025-10-23T14:04:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262459210.md)
  - [en](https://longbridge.com/en/news/262459210.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262459210.md)
---

# ETEK: Yijing Investment plans to reduce its holdings by no more than 3%

According to the Zhitong Finance APP, ETEK (688601.SH) announced that Yijing Investment plans to reduce its holdings of the company's shares by a total of no more than 4.0108 million shares, which is no more than 3% of the company's total share capital, due to its own funding needs through centralized bidding and block trading

### Related Stocks

- [688601.CN](https://longbridge.com/en/quote/688601.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [HSA warns public against consuming herbal remedy containing potent steroid](https://longbridge.com/en/news/287022845.md)
- [Xiaomi EV reportedly taps new battery suppliers for second brand to target EREV market](https://longbridge.com/en/news/286843996.md)
- [Pop star Wang Leehom swaps Denza endorsement fee for BYD stock](https://longbridge.com/en/news/286844734.md)
- [20:00 ETAccro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases](https://longbridge.com/en/news/286830151.md)